Re: A vs V
in response to
by
posted on
Mar 29, 2019 09:27PM
"The "problem" here is that no one knows how Vascepa works."
In fairness, one could say the same of apabetalone. Both Vascepa and Apabetalone affect multiple cardioprotective pathways. Which one(s) are the pathways responsible for the MACE reduction for Vascepa or apabetalone?
BearDownAZ